Saving Access to Laboratory Services Act This bill modifies provisions relating to Medicare payment rates for clinical diagnostic laboratory services, including by requiring payment rates for certain widely available clinical diagnostic laboratory tests to be based on a statistical sampling of private sector rates.
Political Bias In Algorithm Sorting Emails Act of 2022 or the Political BIAS Emails Act of 2022 This bill makes it unlawful for commercial email service providers to use a filtering algorithm to apply a label to an email sent to an email account from a political campaign unless the owner or user of the account took action to apply such label.
Reducing Farm Input Costs and Barriers to Domestic Production Act This bill addresses various provisions related to the regulation of domestic agricultural products, including by requiring the Department of Agriculture to publish criteria for considering requests from meat and poultry establishments to operate at line speeds in excess of the current regulatory limitations. The bill also nullifies the final rule issued by the Council on Environmental Quality on April 20, 2022, that reinstated various National Environmental Policy Act regulatory provisions.
More Options for Infants and Parents Act of 2022 This bill requires the Food and Drug Administration (FDA) to (1) act upon any pending applications from domestic manufacturers for new infant formula within 14 days of the bill's enactment, and (2) maintain a list on its website of infant formula products that may be substituted for certain specialized infant formula products that are in shortage. It also authorizes the FDA to waive certain labeling and nutritional requirements in furtherance of other necessary infant formula product substitutions.
Getting Over Lengthy Delays in Care As Required by Doctors Act of 2022 or the GOLD CARD Act of 2022 This bill exempts physicians from prior authorization requirements under Medicare Advantage plans with respect to specific items and services if at least 90% of the physician's requests for such items and services were approved during the previous plan year.
Babies Need More Formula Now Act of 2022 This bill addresses the regulation of infant formula, including by authorizing the Food and Drug Administration (FDA) to waive certain requirements related to importation. The FDA may waive labeling requirements related to the importation (or distribution or sale) of infant formula from a country with requirements that provide a similar assurance of safety as U.S. requirements. The FDA must, when appropriate, enter into arrangements to harmonize U.S. regulatory requirements pertaining to infant formula with the requirements of other nations. The bill imposes time lines for the FDA to respond to submissions for market approval for new infant formula. The FDA must also issue guidance as to what types of changes in the ingredients of infant formula, if any, may not require a new growth study to meet FDA requirements. The bill also authorizes a person to import, without prior notice to the FDA, up to a three-month supply of infant formula for personal use from a country with formula safety standards similar to U.S. standards, such as Canada. Before recommending or requiring a recall of infant formula due exclusively to a labeling deficiency, the FDA must ensure that the recall will not negatively affect the supply of formula in the United States. The bill also requires the FDA to (1) notify Congress no later than 24 hours after initiating a formula recall, and (2) provide certain information to formula manufacturers about restarting production after an inspection of a manufacturing facility impacted by a recall.
Strengthening Our Health Security Act of 2022 This bill requires the Department of Health and Human Services (HHS) to meet conditions related to notification and planning before terminating certain restrictions on imports and individuals entering the United States. Current law authorizes HHS to restrict entries and imports from foreign countries to prevent the introduction of communicable diseases. HHS exercised this authority as part of its COVID-19 response, including to allow for the expulsion of undocumented migrants at the border without any asylum processing. Under this bill, HHS may not terminate the restrictions for (1) at least 60 days after it notifies Congress of the end of the COVID-19 emergency, and (2) at least 30 days after it submits to Congress a plan for addressing the possible influx of migrants or imports resulting from lifting the restrictions.
This bill prohibits the use of Department of Homeland Security (DHS) funds to carry out the activities of a Disinformation Governance Board or to establish or carry out the activities of any other DHS entity that is substantially similar to the board.
Manufactured Housing Affordability and Energy Efficiency Act of 2022 This bill provides that certain requirements must be met in order for energy conservation standards for manufactured housing (promulgated by the Department of Energy) to become effective.
This bill reduces the amount made available to the National Archives and Records Administration unless it processes and resolves before October 1, 2022, a personnel records backlog of 600,000 requests.
